Carbidopa and Levodopa 50 mg / 1; 200 mg / 1 Tablet 1000 Tablet, Extended Release

NDC 16729-0079-17 is also written 16729007917, or 16729-079-17 (1672907917) in 10-digit form. Reference details for licensed healthcare facility review and verification.

NDC 1116729-0079-17
Product NDC16729-0079
Generic Drug NameCarbidopa and Levodopa
Brand NameCarbidopa And Levodopa
ManufacturerAccord Healthcare, Inc.
Strength50 mg / 1; 200 mg / 1
Dosage FormTablet
Drug TypeOral
Package Quantity1000 Tablet, Extended Release
Package Description1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-079-17)
Active IngredientsCarbidopa; Levodopa
Marketing CategoryANDA

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.

NDC snapshot

Carbidopa and Levodopa 50 mg / 1; 200 mg / 1 Tablet is tracked under NDC 16729-0079-17 and rolls up into product family 16729-0079. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.

  • Package configuration: 1000 Tablet, Extended Release.
  • Manufacturer: Accord Healthcare, Inc..
  • Dosage form: Tablet.
  • Family size: 2 indexed presentations.

Official references

Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.

Alternate presentations in this family

These nearby package-level pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.

Potential alternatives with matching presentation

Open the comparison hub or review package-level listings from 6 product-NDC families with matching normalized presentation details. Review each product detail page before treating any item as a true alternative.

View Potential Alternative HubCarbidopa and levodopa 50 mg / 1; 200 mg / 1 Tablet extended release 1000 Tablet, Extended Release Bottle6 package-level listings in the comparison hub.

Sample package-level pages in this comparison set

Drug Shortage Information

Shortage summary

This NDC appeared in documented shortage listings twice between 2015 and 2017, a recurring history that suggests elevated future supply risk.

This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.

Carbidopa and Levodopa 50 mg / 1; 200 mg / 1 Tablet 1000 Tablet, Extended Release, NDC 16729-0079-17, is a Accord Healthcare, Inc. 50 mg / 1; 200 mg / 1 tablet presentation packaged as 1000 Tablet, Extended Release. Historical public shortage information is available for this product reference.

NDC search formats

  • Canonical NDC 11: 16729-0079-17
  • Digits-only NDC 11: 16729007917
  • Possible 10-digit display format: 16729-079-17 (1672907917)

Helpful product links